Aringhieri Re-elected To Lead Italian Biotech Group
This article was originally published in Scrip
Eugenio Aringhieri has been re-elected for a third term as president of the biotechnology group of the Italian pharmaceutical industry association Farmindustria. The CEO of Italian firm Dompé will serve for a further two years.
You may also be interested in...
The company will invest $1.2bn over the next four years to expand and upgrade its manufacturing capacity for pre-fillable syringes and advanced drug delivery systems across seven manufacturing facilities.
Beneficiaries in nursing homes and in rural areas will benefit from a telehealth expansion in the final CMS physician fee schedule rule.
The data compares the sensitivity of almost 200 diagnostics against a standardized set of samples.